A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Irinotecan
Related studies linked through entity extraction aliases.
A Study of Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLM
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Anlotinib and Irinotecan for Ewing Sarcoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Anlotinib Plus Irinotecan in Patients With Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Phase I Study of Biweekly SIRB Regimen for Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Safety and Efficacy of Pembrolizumab (MK-3475) Plus Binimetinib Alone or Pembrolizumab Plus Chemotherapy With or Without Binimetinib in Metastatic Colorectal Cancer (mCRC) Participants (MK-3475-651/KEYNOTE-651)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE2
Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver
- Status
- COMPLETED
- Phase
- PHASE2
High-dose FOLFIRI in Advanced Colorectal Cancer Patients With Wild-type UGT1A1*6 and *28
- Status
- UNKNOWN
- Phase
- PHASE2
Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair
- Status
- COMPLETED
- Phase
- PHASE1
S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Safety, Tolerability and Pharmacokinetics of Oral Tablet of Irinotecan in Adult Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment With FOLFIRI-aflibercept (for 6 Cycles) Followed by Maintenance With 5FU-aflibercept, in an Elderly Population With mCRC After Failure of an Oxaliplatin-based Regimen
- Status
- COMPLETED
- Phase
- PHASE2